The Artificial Intelligence (AI) in Drug Discovery market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Artificial Intelligence (AI) in Drug Discovery market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Artificial Intelligence (AI) in Drug Discovery market. The report focuses on well-known providers in the global Artificial Intelligence (AI) in Drug Discovery industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Artificial Intelligence (AI) in Drug Discovery Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Artificial Intelligence (AI) in Drug Discovery market covered in Chapter 4:
Atomwise, Inc
DEEP GENOMICS
BERG LLC
Cyclica Inc
OWKIN, INC
Cloud Pharmaceuticals, Inc
Exscientia
Insilico Medicine
twoXAR, Incorporated
BenevolentAI Ltd
XtalPi Inc
NVIDIA Corporation
IBM Corporation
NuMedii, Inc
Numerate
Microsoft
Envisagenics
In Chapter 11 and 13.3, on the basis of types, the Artificial Intelligence (AI) in Drug Discovery market from 2016 to 2027 is primarily split into:
Software
Services
In Chapter 12 and 13.4, on the basis of applications, the Artificial Intelligence (AI) in Drug Discovery market from 2016 to 2027 covers:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Artificial Intelligence (AI) in Drug Discovery Market Share by Type (2021-2027)
1.5.2 Software
1.5.3 Services
1.6 Market by Application
1.6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Share by Application (2021-2027)
1.6.2 Pharmaceutical & Biotechnology Companies
1.6.3 Contract Research Organizations
1.7 Artificial Intelligence (AI) in Drug Discovery Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Artificial Intelligence (AI) in Drug Discovery Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Artificial Intelligence (AI) in Drug Discovery Market
3.1 Value Chain Status
3.2 Artificial Intelligence (AI) in Drug Discovery Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Artificial Intelligence (AI) in Drug Discovery
3.2.3 Labor Cost of Artificial Intelligence (AI) in Drug Discovery
3.2.3.1 Labor Cost of Artificial Intelligence (AI) in Drug Discovery Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Atomwise, Inc
4.1.1 Atomwise, Inc Basic Information
4.1.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.1.3 Atomwise, Inc Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.1.4 Atomwise, Inc Business Overview
4.2 DEEP GENOMICS
4.2.1 DEEP GENOMICS Basic Information
4.2.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.2.3 DEEP GENOMICS Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.2.4 DEEP GENOMICS Business Overview
4.3 BERG LLC
4.3.1 BERG LLC Basic Information
4.3.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.3.3 BERG LLC Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.3.4 BERG LLC Business Overview
4.4 Cyclica Inc
4.4.1 Cyclica Inc Basic Information
4.4.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.4.3 Cyclica Inc Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.4.4 Cyclica Inc Business Overview
4.5 OWKIN, INC
4.5.1 OWKIN, INC Basic Information
4.5.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.5.3 OWKIN, INC Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.5.4 OWKIN, INC Business Overview
4.6 Cloud Pharmaceuticals, Inc
4.6.1 Cloud Pharmaceuticals, Inc Basic Information
4.6.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.6.3 Cloud Pharmaceuticals, Inc Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.6.4 Cloud Pharmaceuticals, Inc Business Overview
4.7 Exscientia
4.7.1 Exscientia Basic Information
4.7.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.7.3 Exscientia Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.7.4 Exscientia Business Overview
4.8 Insilico Medicine
4.8.1 Insilico Medicine Basic Information
4.8.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.8.3 Insilico Medicine Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.8.4 Insilico Medicine Business Overview
4.9 twoXAR, Incorporated
4.9.1 twoXAR, Incorporated Basic Information
4.9.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.9.3 twoXAR, Incorporated Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.9.4 twoXAR, Incorporated Business Overview
4.10 BenevolentAI Ltd
4.10.1 BenevolentAI Ltd Basic Information
4.10.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.10.3 BenevolentAI Ltd Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.10.4 BenevolentAI Ltd Business Overview
4.11 XtalPi Inc
4.11.1 XtalPi Inc Basic Information
4.11.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.11.3 XtalPi Inc Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.11.4 XtalPi Inc Business Overview
4.12 NVIDIA Corporation
4.12.1 NVIDIA Corporation Basic Information
4.12.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.12.3 NVIDIA Corporation Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.12.4 NVIDIA Corporation Business Overview
4.13 IBM Corporation
4.13.1 IBM Corporation Basic Information
4.13.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.13.3 IBM Corporation Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.13.4 IBM Corporation Business Overview
4.14 NuMedii, Inc
4.14.1 NuMedii, Inc Basic Information
4.14.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.14.3 NuMedii, Inc Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.14.4 NuMedii, Inc Business Overview
4.15 Numerate
4.15.1 Numerate Basic Information
4.15.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.15.3 Numerate Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.15.4 Numerate Business Overview
4.16 Microsoft
4.16.1 Microsoft Basic Information
4.16.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.16.3 Microsoft Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.16.4 Microsoft Business Overview
4.17 Envisagenics
4.17.1 Envisagenics Basic Information
4.17.2 Artificial Intelligence (AI) in Drug Discovery Product Profiles, Application and Specification
4.17.3 Envisagenics Artificial Intelligence (AI) in Drug Discovery Market Performance (2016-2021)
4.17.4 Envisagenics Business Overview
5 Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Regions
5.1 Global Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Regions
5.1.1 Global Artificial Intelligence (AI) in Drug Discovery Sales by Regions (2016-2021)
5.1.2 Global Artificial Intelligence (AI) in Drug Discovery Revenue by Regions (2016-2021)
5.2 North America Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
5.3 Europe Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
5.6 South America Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
6 North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Countries
6.1 North America Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Countries
6.1.1 North America Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
6.1.2 North America Artificial Intelligence (AI) in Drug Discovery Revenue by Countries (2016-2021)
6.1.3 North America Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
6.2 United States Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
6.2.1 United States Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
6.3 Canada Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
6.4 Mexico Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7 Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Countries
7.1 Europe Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Countries
7.1.1 Europe Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
7.1.2 Europe Artificial Intelligence (AI) in Drug Discovery Revenue by Countries (2016-2021)
7.1.3 Europe Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.2 Germany Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.2.1 Germany Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.3 UK Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.3.1 UK Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.4 France Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.4.1 France Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.5 Italy Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.5.1 Italy Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.6 Spain Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.6.1 Spain Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
7.7 Russia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
7.7.1 Russia Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Countries
8.1 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8.2 China Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8.3 Japan Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.3.1 Japan Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8.4 South Korea Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.4.1 South Korea Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8.5 Australia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.6 India Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.6.1 India Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
8.7 Southeast Asia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
9 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market Analysis by Countries
9.1 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
9.2 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
9.3 UAE Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
9.4 Egypt Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
9.5 Nigeria Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
9.6 South Africa Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
10 South America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Countries
10.1 South America Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Countries
10.1.1 South America Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
10.1.2 South America Artificial Intelligence (AI) in Drug Discovery Revenue by Countries (2016-2021)
10.1.3 South America Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
10.2 Brazil Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
10.2.1 Brazil Artificial Intelligence (AI) in Drug Discovery Market Under COVID-19
10.3 Argentina Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
10.4 Columbia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
10.5 Chile Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
11 Global Artificial Intelligence (AI) in Drug Discovery Market Segment by Types
11.1 Global Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Artificial Intelligence (AI) in Drug Discovery Sales and Market Share by Types (2016-2021)
11.1.2 Global Artificial Intelligence (AI) in Drug Discovery Revenue and Market Share by Types (2016-2021)
11.2 Software Sales and Price (2016-2021)
11.3 Services Sales and Price (2016-2021)
12 Global Artificial Intelligence (AI) in Drug Discovery Market Segment by Applications
12.1 Global Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Artificial Intelligence (AI) in Drug Discovery Sales and Market Share by Applications (2016-2021)
12.1.2 Global Artificial Intelligence (AI) in Drug Discovery Revenue and Market Share by Applications (2016-2021)
12.2 Pharmaceutical & Biotechnology Companies Sales, Revenue and Growth Rate (2016-2021)
12.3 Contract Research Organizations Sales, Revenue and Growth Rate (2016-2021)
13 Artificial Intelligence (AI) in Drug Discovery Market Forecast by Regions (2021-2027)
13.1 Global Artificial Intelligence (AI) in Drug Discovery Sales, Revenue and Growth Rate (2021-2027)
13.2 Artificial Intelligence (AI) in Drug Discovery Market Forecast by Regions (2021-2027)
13.2.1 North America Artificial Intelligence (AI) in Drug Discovery Market Forecast (2021-2027)
13.2.2 Europe Artificial Intelligence (AI) in Drug Discovery Market Forecast (2021-2027)
13.2.3 Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Forecast (2021-2027)
13.2.4 Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market Forecast (2021-2027)
13.2.5 South America Artificial Intelligence (AI) in Drug Discovery Market Forecast (2021-2027)
13.3 Artificial Intelligence (AI) in Drug Discovery Market Forecast by Types (2021-2027)
13.4 Artificial Intelligence (AI) in Drug Discovery Market Forecast by Applications (2021-2027)
13.5 Artificial Intelligence (AI) in Drug Discovery Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Artificial Intelligence (AI) in Drug Discovery Market Size Growth Rate by Type (2021-2027)
Figure Global Artificial Intelligence (AI) in Drug Discovery Market Share by Type in 2020 & 2026
Figure Software Features
Figure Services Features
Table Global Artificial Intelligence (AI) in Drug Discovery Market Size Growth by Application (2021-2027)
Figure Global Artificial Intelligence (AI) in Drug Discovery Market Share by Application in 2020 & 2026
Figure Pharmaceutical & Biotechnology Companies Description
Figure Contract Research Organizations Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Artificial Intelligence (AI) in Drug Discovery Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Artificial Intelligence (AI) in Drug Discovery Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Artificial Intelligence (AI) in Drug Discovery
Figure Production Process of Artificial Intelligence (AI) in Drug Discovery
Figure Manufacturing Cost Structure of Artificial Intelligence (AI) in Drug Discovery
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Atomwise, Inc Profile
Table Atomwise, Inc Production, Value, Price, Gross Margin 2016-2021
Table DEEP GENOMICS Profile
Table DEEP GENOMICS Production, Value, Price, Gross Margin 2016-2021
Table BERG LLC Profile
Table BERG LLC Production, Value, Price, Gross Margin 2016-2021
Table Cyclica Inc Profile
Table Cyclica Inc Production, Value, Price, Gross Margin 2016-2021
Table OWKIN, INC Profile
Table OWKIN, INC Production, Value, Price, Gross Margin 2016-2021
Table Cloud Pharmaceuticals, Inc Profile
Table Cloud Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2016-2021
Table Exscientia Profile
Table Exscientia Production, Value, Price, Gross Margin 2016-2021
Table Insilico Medicine Profile
Table Insilico Medicine Production, Value, Price, Gross Margin 2016-2021
Table twoXAR, Incorporated Profile
Table twoXAR, Incorporated Production, Value, Price, Gross Margin 2016-2021
Table BenevolentAI Ltd Profile
Table BenevolentAI Ltd Production, Value, Price, Gross Margin 2016-2021
Table XtalPi Inc Profile
Table XtalPi Inc Production, Value, Price, Gross Margin 2016-2021
Table NVIDIA Corporation Profile
Table NVIDIA Corporation Production, Value, Price, Gross Margin 2016-2021
Table IBM Corporation Profile
Table IBM Corporation Production, Value, Price, Gross Margin 2016-2021
Table NuMedii, Inc Profile
Table NuMedii, Inc Production, Value, Price, Gross Margin 2016-2021
Table Numerate Profile
Table Numerate Production, Value, Price, Gross Margin 2016-2021
Table Microsoft Profile
Table Microsoft Production, Value, Price, Gross Margin 2016-2021
Table Envisagenics Profile
Table Envisagenics Production, Value, Price, Gross Margin 2016-2021
Figure Global Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Global Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales by Regions (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Regions (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue ($) by Regions (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share by Regions (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share by Regions in 2016
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share by Regions in 2020
Figure North America Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Europe Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure South America Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure North America Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth (2016-2021)
Table North America Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
Table North America Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Countries (2016-2021)
Figure North America Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Countries in 2016
Figure United States Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Canada Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Mexico Artificial Intelligence (AI) in Drug Discovery Sales and Growth (2016-2021)
Figure Europe Artificial Intelligence (AI) in Drug Discovery Revenue ($) Growth (2016-2021)
Table Europe Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
Table Europe Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Countries (2016-2021)
Figure Germany Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure UK Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure France Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Italy Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Spain Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Russia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
Table Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Countries (2016-2021)
Figure China Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Japan Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure South Korea Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Australia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure India Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Southeast Asia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales by Countries (2016-2021)
Table Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure UAE Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Egypt Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Nigeria Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure South Africa Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure South America Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth (2016-2021)
Figure Brazil Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Argentina Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Columbia Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Figure Chile Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales by Types (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue ($) by Types (2016-2021)
Figure Global Software Sales and Growth Rate (2016-2021)
Figure Global Software Price (2016-2021)
Figure Global Services Sales and Growth Rate (2016-2021)
Figure Global Services Price (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales by Applications (2016-2021)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Share by Applications (2016-2021)
Figure Global Pharmaceutical & Biotechnology Companies Sales and Growth Rate (2016-2021)
Figure Global Pharmaceutical & Biotechnology Companies Revenue and Growth Rate (2016-2021)
Figure Global Contract Research Organizations Sales and Growth Rate (2016-2021)
Figure Global Contract Research Organizations Revenue and Growth Rate (2016-2021)
Figure Global Artificial Intelligence (AI) in Drug Discovery Sales and Growth Rate (2021-2027)
Figure Global Artificial Intelligence (AI) in Drug Discovery Revenue ($) and Growth Rate (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Forecast by Regions (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Forecast by Regions (2021-2027)
Figure North America Artificial Intelligence (AI) in Drug Discovery Sales Forecast (2021-2027)
Figure North America Artificial Intelligence (AI) in Drug Discovery Revenue Forecast (2021-2027)
Figure Europe Artificial Intelligence (AI) in Drug Discovery Sales Forecast (2021-2027)
Figure Europe Artificial Intelligence (AI) in Drug Discovery Revenue Forecast (2021-2027)
Figure Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Sales Forecast (2021-2027)
Figure Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Revenue Forecast (2021-2027)
Figure Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Sales Forecast (2021-2027)
Figure Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Revenue Forecast (2021-2027)
Figure South America Artificial Intelligence (AI) in Drug Discovery Sales Forecast (2021-2027)
Figure South America Artificial Intelligence (AI) in Drug Discovery Revenue Forecast (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Forecast by Types (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Market Share Forecast by Types (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share Forecast by Types (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Sales Market Share Forecast by Applications (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Forecast by Applications (2021-2027)
Table Global Artificial Intelligence (AI) in Drug Discovery Revenue Market Share Forecast by Applications (2021-2027)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|